Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome
|
|
- Letitia McKinney
- 5 years ago
- Views:
Transcription
1 British Journal of Obstetrics and Gynaecology January 1998, Vol. 105, pp Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome Khaldoun Sharif Lecturer, Manal Elgendy Research Fellow, Hany Lashen Research Fellow, Masoud Afnan Senior Lecturer Assisted Conception Unit, Birmingham Women j. Hospital Objective To examine the relative effect of basal follicle stimulating hormone (FSH) concentration and the woman s age on predicting the ovarian response to gonadotrophin stimulation, normal fertilisation rate and pregnancy rate in in vitro fertilisation (IVF) treatment following pituitary desensitisation. Design Descriptive cohort study. Participants Three hundred and forty-four women undergoing their first IVF cycle. Methods Basal (menstrual-day 3) FSH concentration was measured and the woman s age calculated before she underwent pituitary desensitisation followed by gonadotrophin ovarian stimulation and IVF treatment. Main outcome measures Cancellation rate due to poor ovarian response, total dose of gonadotrophin required to achieve follicular maturity, number of oocytes collected, normal fertilisation rate and pregnancy rate were compared between banded values of the variables studied. Results Increasing basal FSH concentration was associated significantly with increased cancellation rate, but increasing age was not. Both increasing basal FSH and age were associated significantly with increased total gonadotrophin dose, and reduced number of oocytes collected and pregnancy rate. Analysis of variance showed that the association for basal FSH with the number of oocytes was significant, independent of, and stronger than the effects of age. Logistic regression analysis showed that age, but not basal FSH, was independently associated with pregnancy rate. Neither basal FSH, nor age had significant association with normal fertilisation rate. Conclusion Basal FSH concentration is a better predictor of cancellation rate and of the number of oocytes collected in IVF treatment than age, but age is a stronger predictor of pregnancy rate. INTRODUCTION One of the factors that infertile couples take into consideration before deciding to embark on in vitro fertilisation treatment is the expected chances of achieving a pregnancy. Advancing age in the woman is well recognised to reduce natural fertility as well as the chances of pregnancy after all types of infertility treatment, including IVF1q2. As the menopause approaches, the chances of pregnancy decline. However, different women reach the menopause at different ages, and it is biologically plausible that the age-related decline in fertility may occur at different rates in different women. Age alone has limited predictive value, and it would be helpful, for both patient counselling and clinical management, to have another independent prognostic factor that can predict the true reproductive potential of each woman individually. One study3 has reported that women may Correspondence: Dr K. Sharif, Assisted Conception Unit, Birmingham Women s Hospital, Birmingham B15 2TG, UK. begin to have a subtle increase in their serum follicle stimulating hormone concentrations in their mid-thirties, coinciding with the time at which fertility begins to decline. Subsequently, another studf has shown that the earliest increase in FSH occurs in the early follicular phase. The use of early follicular phase (basal) serum FSH concentration was described by Scott et ~ 1 of. the ~ Jones institute, Norfolk, Virginia, USA, as a predictor of IVF outcome and was found by Toner et ~ 1 to. be ~ more predictive than age. However, Toner et al6 used pituitary desensitisation (which is now used in most IVF programmes) in only 38% of their study cycles and did not report on the analysis of those cycles separately. Furthermore, they transferred up to four embryos per woman; the maximum number allowed by law in the UK is three embryos, and many other countries have similar limits. Here again the analysis of their pregnancy rates (which are well recognised to correlate with the number of embryos transferred) may not be applicable in the UK. More recently, Cahill et al. reported on 0 RCOG 1998 British Journal of Obstetrics and Gynaecology 107
2 108 K. SHARIF ET AL. 171 IVF cycles following pituitary desensitisation and demonstrated the superior predictive value of basal FSH over age on ovarian response. However, they did not study the effect on cancellation rate (a major problem in poor responders), fertilisation rate or pregnancy rate (due to relatively small sample size). We report here on the analysis of the predictive value of basal FSH and age on cancellation rate, total dose of gonadotrophins, number of oocytes collected, normal fertilisation rate and pregnancy rate in 344 women undergoing their first IVF cycle after pituitary desensitisation. METHODS We studied 344 consecutive women undergoing their first IVF cycle at our unit between August 1994 and July Only first cycles were studied to avoid possible bias from experience of ovarian response in previous cycles. The indications for treatment were: tuba1 damage (40%), sperm dysfunction (35%) endometriosis (7%), unexplained infertility (13%) and ovulatory dysfunction (5%). Age was calculated as completed years on the day of starting ovarian stimulation. The serum FSH concentration was measured on day 3 of the period preceding the treatment cycle. Hormone assays Serum FSH concentration was measured using the Ciba Coring ACS FSH assay; a two-site chemiluminometric (sandwich) immunoassay using ACS 180 immunoanalyser (Ciba Coring Diagnostic Corporation, Massachusetts, USA). The assay was standardised against the World Health Organisation 2nd IRP 94/632 reference material. The in-house withm-batch coefficients of variation for this assay (determined by replicate analysis) were 456% at 5.13 IUL (n = 12), 4.06% at IUL (n = 12) and 4.92% at 47 IUL (n = 12). The betweenbatch corresponding values were 7.32% at 8.64 IUL (n = 127), 6.61% at IU/L (n = 52) and 9.53% at IUL (n = 107). In our laboratory the upper limit of normal (95th centile) for early follicular phase FSH was 10.8 IUL. Treatment protocol We followed protocols for desensitisation, ovarian stimulation, egg collection, gamete handling, embryo transfer and luteal support as described previou~ly~>~. Basically, gonadotrophin releasing hormone analogue (Nafarelin, Syntex, Berkshire, UK), 200 pg three times daily via nasal spray, was used for pituitary desensitisation (long protocol; starting from the mid-luteal phase of the previous cycle), followed by ovarian stimulation with human menopausal gonadotrophin (Metrodin HP, Serono, Welwyn Garden City, UK). We used a flat-dose protocol where a constant daily dose of gonadotrophin was administered according to the woman s age; three ampoules (75 IU each) for women aged 35 years or younger, four ampoules for women aged between 36 and 39 years, and six ampoules for women 40 years and older. Ovarian response was monitored using vaginal ultrasound scan. Human chorionic gonadotrophin (hcg) (Profasi, Serono, UK) 10,000 units were administered when there was a leading follicle of mm mean diameter and at least another three follicles over 14 mm. Twenty-eight women with three or fewer follicles > 14 mm mean diameter after 14 days of stimulation were considered to have poor response and counselled regarding cancelling their treatment cycle; all agreed to cancel treatment. Ultrasound directed oocyte retrieval was performed 36 hours after the hcg injection. Embryo transfer was performed hours following oocyte retrieval and progesterone (Gestone, Paines and Byrne, Surrey, UK) 100 mg/day (intramuscular) was given for luteal support. A urinary pregnancy test was performed two weeks following the embryo transfer and, if positive, a scan was performed at four weeks post-transfer. A clinical pregnancy was defined as that with fetal heart motion on ultrasound scan and a biochemical pregnancy as that where miscarriage has occurred before demonstrating fetal heart motion on scan. Analysis of results The end points studied were: cancellation rate for poor response, total dose of gonadotrophins used (calculated as the total number of ampoules used), number of oocytes collected, normal fertilisation rate (number of embryos with two pronuclei on day 1 following egg collection divided by the number of oocytes collected) and pregnancy rate per cycle. Dichotomous categorical variables were used to describe and analyse the data on cancellation rate and pregnancy rate. Continuous variables were used with the other end points. The independent variables studied were the woman s age and her basal FSH concentration. Continuous variables were examined for normalcy; logarithmic transformation was used where necessary to produce acceptable Gaussian distribution. The variables of age and basal FSH were banded for analysis into arbitrary interval groups. For age, there were four age groups: group years (n = 11 1, 32.3%); group 2 > years (n = 119, 34.6%); group 3 > 35 to < 40 years (n = 82,23.8%); and group years (n = 32, 9.3%). For FSH, there were three groups: FSH group IU/L (n = 39, 11.3%); FSH group 2 > 5.4 to < 10.8 IU/L (n = 273,79.4%); and FSH group IU/L (n = 32,9*3%).
3 ~~ ~ AGE AND FSH AS PREDICTORS OF IVF OUTCOME 109 Table 1. Age, basal serum follicle stimulating hormone (FSH), and number of eggs collected, embryos formed, and embryos transferred in the study population (n = 344). Median (range) Age (years) 33 (22-46) Basal FSH (IU/L) 7.25 (3-27) Total dose 33 (11-104) Eggs collected 9 (1-34) Fertilisation rate (%) 53 (0-100) Embryos formed 4 (0-23) Embryos transferred 3 (1-3) Interquartile range The effects of basal FSH concentration and age on the outcome variables were analysed using the two-sample t test and x2, as appropriate. In variables with which both FSH and age were found to have significant association, the relationship was further examined using a two-way analysis of variance (factorial ANOVA) employing the general linear model for continuous variables (total dose and number of oocytes) and logistic regression for binary variables (pregnancy). The software Stat- View (version 4.5, Abacus Concepts, California, USA) was used for analysis and statistical significance was assumed at P RESULTS All the 344 women had successful pituitary down regulation and started ovarian stimulation. Twenty-eight women (8.1%) had cancelled cycles because of poor ovarian response and did not proceed to egg collection. The remaining 316 women (9109%) had egg collection. Thirty-five women (10.2%) had total failure of fertilisation and the remaining 281 (81.7%) proceeded to embryo transfer. Of these, 178 (51.7%) had a negative pregnancy test and the remaining 103 had a positive test, yielding a 29.9% pregnancy rate per cycle started. Of these pregnancies 82 were clinical (2343% clinical pregnancy rate per cycle), 18 (5.2%) were biochemical, and three (047%) were ectopic. Table 1 shows the distribution of the age, basal FSH concentration, and the number of oocytes collected, embryos formed and embryos transferred in the study population. As shown in Fig. la, the cancellation rate in FSH groups 1 and 2 (normal values) were 5.1% and 54?%, respectively. In FSH group 3 it was 31-2%, considered a highly significant difference (P = ). On the other hand, as shown in Fig. 2a, there was no significant difference between the cancellation rate between different age groups (P = 0.98). Increased basal FSH concentration, as well as increased age, were significantly associated with increasing total gonadotrophin dose required (Figs lb and 2b), and a reduction in the number of oocytes Table 2. Two-way analysis of variance: probability of main effects. Age FSH AgexFSH Total dose < 0~0001 < 0~ No. of eggs collected collected (Figs lc and 2c). Of course, by virtue of our treatment protocol-where older women were given higher daily doses-there would be a significant increase in total dose with increased age, and no firm conclusions could be drawn from our study about the effect of age on the total gonadotrophin dose required. However, it is worth noting that this significant association (P = ) was also present between age groups one (I 30 years) and two (> 30 and I 35); women in both these groups received the same daily dose in our protocol, yet their total dose significantly increased with increasing age. Neither basal FSH concentration, nor the woman's age were significantly correlated with the normal fertilisation rate, as evident by the wide and overlapping confidence intervals in Figs Id and 2d. This applied whether all the couples were considered or only those with no male factor infertility (data not shown). In order to examine the effect of increased basal FSH concentration and age on pregnancy rate, these variables were analysed in a dichotomous categorical fashion; as normal and abnormal ( IUL) for FSH, and as I 35 or > 35 years for age. This was necessary to increase the power of the analysis due to the relatively small numbers. Both variables showed a statistically significant effect on pregnancy rate (Figs le and 2e). Thus, significant associations were found between both basal FSH concentration and age on one hand and the total dose and the number of oocytes collected on the other hand. Two-way analysis of variance was then employed in order to examine the independent (main) as well as the combined effect (interaction) of FSH and age (Table 2). The analysis of variance was applied about the age of 40 years and FSH of 10.8 Iu/L (both corresponding to the 95th centile). Both basal FSH concentration and age showed significant and independent associations with the total dose. Basal FSH, but not age, showed significant independent association with the number of oocytes collected. Logistic regression analysis showed that age (P = 0-01), but not basal FSH concentration (P = 0-l), was significantly associated with pregnancy rate; the significant association between FSH and pregnancy rate disappeared when controlled for age. DISCUSSION The results of this study have shown that age and basal FSH are predictive factors of the outcome of IVF
4 110 K. SHARIF J* ET AL 6o r v 8 30 c Q & 10 n I I I Normal Abnormal Fig. 1. Outcome measures (geometric means and 95% CI) related to FSH groups (group 1 I5.4 IU/L, group 2 > 5.4 to < 10.8 IU/L, group IU/L; groups 1 and 2 normal, group 3 abnormal). *P= , tp = (x2 test); $ P = 0.001, P= (two-sample 1 test). treatment following pituitary desensitisation. Their predictive values, however, seem to manifest in different ways. This may have several implications for counselling and clinical management, particularly for women younger than 35 years with abnormally high basal FSH concentration who would have been expected to perform differently on age basis alone. Cancellation rates for poor response were similar (7% to 8%) between different age groups, but differed significantly with basal FSH, rising from about 5% in women with concentration < 10.8 IU/L to over 30% in those with IU/L. To the best of our knowledge, this is the first reported study addressing this issue. Women with high basal FSH concentration should be counselled accordingly. The total gonadotrophin dose required to achieve follicular maturity increased significantly with increasing both age and basal FSH. As discussed above, part (but not all) of this increase with age could be explained by our treatment protocol. The increase with basal FSH, however, was highly significant and independent of the effect of age (Table 2). Drug cost forms a major component of the total cost of IVF treatment, and women with high basal FSH, particularly if older than 35 years, should be alerted to the high possibility of needing higher (more costly) total dose. Despite using higher total gonadotrophin dose with advancing age and increased basal FSH concentration, these two parameters were significantly associated with fewer oocytes retrieved. The effect of basal FSH concentration was independent of and more significant than that of age. Fewer oocytes will lead to fewer embryos available for either transfer or cryopreservation. Women with high basal FSH concentration should be warned that it is likely that they will have fewer oocytes collected and fewer (or perhaps no) embryos for cryopreservation.
5 AGE AND FSH AS PREDICTORS OF IVF OUTCOME c I I I I u) - a, 3 g Q u) - 40 m c ' a, L I I I I I T T T 1 I I I - * o o I I > Weeks Fig. 2. Outcome measures (geometric means and 95% CI) related to age groups (group 1 I 30 years, group 2 > years, group 3 > 35 to < 40 years, group years). *P = , tp = (two-sample t test);$ P = 0.01 (x2 test). Interestingly, the normal fertilisation rate did not differ significantly with either age or basal FSH concentration. This finding is in apparent contrast to that by Toner et al6 whose results indicated that both increased age and basal FSH were significantly associated with reduced number of fertilised oocytes. A possible explanation of this difference may lie in the fact that we have looked at the fertilisation rate while they have looked at the number of fertilised oocytes; fewer oocytes collected (which is the case with increased age and basal FSH) will lead to fewer embryos formed even in the presence of constant fertilisation rate. We have also found that the pregnancy rate per cycle decreased significantly with increasing both basal FSH concentration and age. Logistic regression analysis showed that the effect of basal FSH was not independent; increasing age alone could explain the associated decrease in pregnancy rate. This finding was in contrast to that by Toner et al. who found that basal FSH concentration was independent of, and stronger than age in significantly predicting pregnancy rate after IVF6. Their sample size (n = 1478) was much larger than ours and this may explain the apparently conflicting findings. An alternative explanation might be that all our patients had prior pituitary desensitisation compared with about one-third of their patients. Pituitary desensitisation may in some way modulate the effect of high basal FSH concentration on pregnancy rate. A larger study than ours is needed to clarify this point. We did not examine the association with miscarriage rate, clinical pregnancy rate or live birth rate. The numbers in our study were too small to make such analysis statistically meaningful.
6 112 K. SHARIF ET AL. Some statistical issues in our study deserve comment. When similar data have been handled in the literature previously, two statistical methods have been used. The first is linear regression analysis, where full advantage is taken of continuous data with out introducing arbitrary cut off points (e.g. different FSH and age group) as these may bias the results6. The second method used is to divide the continuous variables into banded values and analyse them as groups. We have elected to use the latter method in presenting these data for several reasons. First, clinicians usually think of, and work with, numerical results in a categorical fashion: normal or abnormal FSH (> 95th centile). Second, we believe that this method lends itself to more clarity when presented in graphs. Finally, we have also analysed our data by regression analysis (results not shown) and found similar results. The difference is in the form, not the substance. Currently it is not known whether the ovarian response and IVF outcome of women with high basal FSH concentration could be improved by altering the stimulation regimen (e.g. using the flare-up protocol or increasing the dose of gonadotrophin). The available data relate to high dose stimulation in those who have shown poor response in previous IVF cycles, regardless of their basal FSH concentrationlo. These data suggest that although the number of oocytes is significantly increased, the pregnancy rate remained very low lo. Currently some IVF clinicians would choose to extrapolate from those data and keep women with high basal FSH undergoing their first IVF cycle on the standard regimen, while others would increase their stimulation dose. The correct action is not known and perhaps the best action is to enrol these in a prospective randomised trial. Finally, a few practical points are worth mentioning in the context of measuring basal FSH concentration. First, we have measured FSH on menstrual day 3 to achieve consistency and comparability with previous studies. Nonetheless, it has been shown that the variability in FSH concentrations during menstrual days 2-5 is not significant, and it could be measured in practice on any of those days*. Second, basal FSH concentration does not have to be measured during the cycle immediately preceding the IVF treatment; the small intercycle variability is such that abnormally high levels in any previous cycle carry the same prognostic significancei2. The final point is to do with the upper limit of normal: it is very different in different assays (ranging from 9 to 22 IU/L)6,7. Clinicians should be aware of the normal limits in their local laboratories. CONCLUSION Our study has demonstrated that, in IVF treatment following pituitary desensitisation, basal FSH concentration is a better predictor of cancellation rate and of the number of oocytes collected than age, but age is a stronger predictor of pregnancy rate. The effect of basal FSH on pregnancy rate lost its significance when controlled for age. Many prognostic factors have been shown to correlate with the chances of achieving pregnancy after IVF treatment. These include the duration of infertility, previous pregnancy, the number and outcome of previous IVF attempts, and the woman s age. We recommend the addition of basal FSH concentration to those factors to individualise pre-treatment counselling for patients. Acknowledgement We would like to thank the clinical, nursing and laboratory staff at the Assisted Conception Unit for their assistance in collecting these data. References Federation CECOS, Schwartz D, Mayaux BA. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. N Engl J Med 1982; 306: Templeton A, Moms JK, Parslow W. Factors that affect outcome of in-vitro fertilisation treatment. Lancet 1996; 348: Sherman BM, Korenman SG. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest 1975; 55: Lenton EA, Sexton L, Lee S, Cook ID. Progressive changes in LH and FSH and LH: FSH ratio in women throughout reproductive life. Maturitas 1988; Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks 2. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Ferfil Steril 1989; 51: Toner JP, Philput CB, Jones GS, Muasher SJ. Basal follicle stimulating hormone level is a better predictor of in vitro fertilisation performance than age. Feriil Steril1991; 55: Cahill DJ, Prosser CJ, Wardle PG, Ford WCL, Hull MGR. Relative influence of serum follicle stimulating hormone, age, and other factors on ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecoll994; 101: Sharif K, Afnan M, Lenton W. Mock embryo transfer with a full-bladder immediately before the real transfer for in-vitro fertilisation treatment: the Birmingham experience of 113 cases. Hum Reprod 1995; 10: Sharif K, Afnan M, Lenton W, Bilalis D, Hunjan M, Khalaf Y. Transmyometrial embryo transfer following difficult immediate mock transcervical transfer. Fertil Steril1996: 56: Land JA, Yarmolinskaya MI, Dumoulin JCM, Evers JLH. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996; 65: Hansen LM, Batzer FR, Gutmann JN, Corson SL, Kelly MP, Gocial B. Evaluating ovarian reserve: follicle stimulating hormone and oestradiol variability during cycle days 2-5. Hum Reprod 1996; 11: Scott RT, Hofmann GE, Oehninger S, Muasher S3. Intercycle vanability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 1990; 54: Received 26 February 1997 Returnedfor revision 4 July 1997 Accepted 23 July 1997
in vitro fertilization
FERTILITY AND STERILITY VOL 69, NO. 6, JUNE 1998 Copyright (#1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Elevated levels of basal
More informationIVF treatment should not be postponed for patients with high basal FSH concentrations
Reproductive BioMedicine Online (2010) 21, 631 635 www.sciencedirect.com www.rbmonline.com SHORT COMMUNICATION IVF treatment should not be postponed for patients with high basal FSH concentrations Ettie
More informationIVF Performance of Women Who Have Fluctuating Early Follicular FSH Levels 1
CLINICAL ASSISTED REPRODUCTION IVF Performance of Women Who Have Fluctuating Early Follicular FSH Levels 1 A. LASS, 2,3 A. GERRARD, 2 N. ABUSHEIKHA, 2 F. AKAGBOSU, 2 and P. BRINSDEN 2 Submitted: April
More informationTimur Giirgan, M.D.* Bulent Urman, M.D. Hakan Yarali, M.D. Hakan E. Duran, M.D.
FERTILITY AND STEFULI~ Vol. 68, No. 3, September 1997 Copyright 1997 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Published by Elsevier Science Inc. Follicle-stimulating
More informationOvarian response in three consecutive in vitro fertilization cycles
FERTILITY AND STERILITY VOL. 77, NO. 4, APRIL 2002 Copyright 2002 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Ovarian response in
More informationAgonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M
Agonist versus antagonist in ICSI cycles: a randomized trial and cost effectiveness analysis Badrawi A, Zaki S, Al-Inany H, Ramzy A M, Hussein M Record Status This is a critical abstract of an economic
More informationIN VITRO FERTILIZATION
FERTILITY AND STERILITY VOL. 79, NO. 1, JANUARY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION
More informationElena H. Yanushpolsky, M.D., a Shelley Hurwitz, Ph.D., b Eugene Tikh, B.S., c and Catherine Racowsky, Ph.D. a
FERTILITY AND STERILITY VOL. 80, NO. 1, JULY 2003 Copyright 2003 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Predictive usefulness of cycle
More informationFemale Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF
Female Reproductive Physiology Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF REFERENCE Lew, R, Natural History of ovarian function including assessment of ovarian reserve
More informationSignificance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization*
FERTILITY AND STERILITY Copyright e 1992 The American Fertility Society Printed on acid-free paper in U.S.A. Significance of basal follicle-stimulating hormone levels in women with one ovary in a program
More informationLOW RESPONDERS. Poor Ovarian Response, Por
LOW RESPONDERS Poor Ovarian Response, Por Patients with a low number of retrieved oocytes despite adequate ovarian stimulation during fertility treatment. Diagnosis Female About Low responders In patients
More informationInternational Federation of Fertility Societies. Global Standards of Infertility Care
International Federation of Fertility Societies Global Standards of Infertility Care Standard 8 Reducing the incidence of multiple pregnancy following treatment for infertility Name Version number Author
More informationArticle Relevance of basal serum FSH to IVF outcome varies with patient age
RBMOnline - Vol 17. No 1. 2008 10-19 Reproductive BioMedicine Online; www.rbmonline.com/article/3144 on web 16 May 2008 Article Relevance of basal serum FSH to IVF outcome varies with patient age Dr Luca
More informationFixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol
Yamanashi Med. J. 14(3), 77 ~ 82, 1999 Original Article Fixed Schedule for in vitro Fertilization and Embryo Transfer: Comparison of Outcome between the Short and the Long Protocol Tsuyoshi KASAI and Kazuhiko
More informationIn Vitro Fertilization and Embryo Transfer
Acta Medica et Biologica Vol. 41, No.4, 171-176, 1993 The Influence of Low Ovarian Response on the Results of In Vitro Fertilization and Embryo Transfer Hirofumi HIRASAWA Department of Obstetrics and Gynecology,
More informationlbt lab tests t Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour
lbt lab tests t and Conrolled Ovarian Hyperstimulation Dr Soheila Ansaripour Research Instituteof Avicenna 4/23/2012 Why good prediction of poor response good prediction i of OHSS application appropriate
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 22 September 2010
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 22 September 2010 100 µg/0.5 ml, solution for injection B/1 prefilled syringe + 1 needle (CIP code: 374 590-1) 150
More informationThe association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age
Reproductive BioMedicine Online (2010) 21, 757 761 www.sciencedirect.com www.rbmonline.com ARTICLE The association between anti-müllerian hormone and IVF pregnancy outcomes is influenced by age Jeff G
More informationNICE fertility guidelines. Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic
NICE fertility guidelines Hemlata Thackare MPhil MSc MRCOG Deputy Medical Director London Women s Clinic About the LWC 4 centres around the UK London Cardiff Swansea Darlington The largest sperm bank in
More informationDoes previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation treatment cycles?
J Assist Reprod Genet (26) 23:427 431 DOI 1.17/s1815-6-965-x ASSISTED REPRODUCTION Does previous response to clomifene citrate influence the selection of gonadotropin dosage given in subsequent superovulation
More informationInfertility in Women over 35. Alison Jacoby, MD Dept. of Ob/Gyn UCSF
Infertility in Women over 35 Alison Jacoby, MD Dept. of Ob/Gyn UCSF Learning Objectives Review the effect of age on fertility Fertility counseling for the patient >35 - timing - lifestyle - workup Fertility
More informationEvaluation of basal estradiol levels in assisted reproductive technology cycles
FERTILITY AND STERILITY VOL. 74, NO. 3, SEPTEMBER 2000 Copyright 2000 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Evaluation of basal
More informationAnalysis of factors affecting embryo implantation
Analysis of factors affecting embryo implantation Andrew L.Speirst, H.W.G.Baker and Nusratudin Abdullah The Royal Women's Hospital, Melbourne, Australia ITo whom correspondence should be addressed Introduction
More informationEstradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success
DOI 10.1007/s13224-014-0515-6 ORIGINAL ARTICLE Estradiol Level on Day 2 and Day of Trigger: A Potential Predictor of the IVF-ET Success Prasad Sudha Kumar Yogesh Singhal Megha Sharma Shashi Received: 27
More informationType of intervention Treatment. Economic study type Cost-effectiveness analysis.
Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness Gerli S, Casini M L, Unfer V, Costabile L, Bini V,
More informationInterpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used
Interpreting follicular Progesterone: Late follicular Progesterone to Estradiol ratio is not influenced by protocols or gonadotropins used Ellenbogen A., M.D., Shalom-Paz E., M.D, Asalih N., M.D, Samara
More informationA prospective randomized study comparing aspiration only with aspiration and flushing for transvaginal ultrasound-directed oocyte recovery
FERTILITY AND STERILITY Vol. 58, No.2, August 1992 Copyright e 1992 The American Fertility Society Printed on acid-free paper in U.S.A. A prospective randomized study comparing aspiration only with aspiration
More informationSummary
Summary 118 This thesis is focused on the background of elevated levels of FSH in the early follicular phase of women with regular menstrual cycles. In the introduction (chapter 1) we describe the characteristics
More informationPredictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older
Reprod Med Biol (2009) 8:145 149 DOI 10.1007/s12522-009-0023-z ORIGINAL ARTICLE Predictive factors of successful pregnancy after assisted reproductive technology in women aged 40 years and older Akihisa
More informationOvulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age*
FERTILITY AND STERILITY Vol. 58, No.4, October 1992 Copyright It! 1992 The American Fertility Society Printed on acid-free paper in U. S.A. Ovulation induction in women age 40 and older: the importance
More informationAssisted Reproduction. By Dr. Afraa Mahjoob Al-Naddawi
Assisted Reproduction By Dr. Afraa Mahjoob Al-Naddawi Learning Objectives: By the end of this lecture, you will be able to: 1) Define assisted reproductive techniques (ART). 2) List indications for various
More informationPrinciples of Ovarian Stimulation
Principles of Ovarian Stimulation Dr Genia Rozen Gynaecologist and Fertility Specialist Royal Women s Hospital and Melbourne IVF Learning objectives Why ovarian stimulation Recap physiology Ovarian cycle
More informationAbstract. Introduction. Materials and methods
RBMOnline - Vol 10. No 5. 2005 645 649 Reproductive BioMedicine Online; www.rbmonline.com/article/1518 on web 18 March 2005 Article Factors predicting IVF treatment outcome: a multivariate analysis of
More informationIN VITRO FERTILIZATION
FERTILITY AND STERILITY VOL. 82, NO. 4, OCTOBER 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. IN VITRO FERTILIZATION Prognostic
More informationDoes triggering ovulation by 5000 IU of uhcg affect ICSI outcome? *
Middle East Fertility Society Journal Vol. 11, No. 2, 2006 Copyright Middle East Fertility Society Does triggering ovulation by 5000 IU of uhcg affect ICSI outcome? * Amany A.M. Shaltout, M.D. Mohamed
More informationOvarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy
Ovarian Response to Gonadotrophin Stimulation in Patients with Previous Endometriotic Cystectomy M.E. Coccia, F. Cammilli, L. Ginocchini, F. Borruto* and F. Rizzello Dept Gynaecology Perinatology and Human
More informationIntercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization*
FERTILITY AND STERILITY Copyright C> 1990 The American Fertility Society Printed on acid-free paper in U.S.A. Inter variability of day 3 follicle-stimulating hormone levels and its effect on stimulation
More informationNeil Goodman, MD, FACE
Initial Workup of Infertile Couple: Female Neil Goodman, MD, FACE Professor of Medicine Voluntary Faculty University of Miami Miller School of Medicine Scope of Infertility in the United States Affects
More informationF.Zayed 1 ' 3, E.A.Lenton 1 ' 2 and I.D.Cooke 2
Human Reproduction vol.12 no. 11 pp.2408-2413, 1997 Comparison between stimulated in-vitro fertilization and stimulated intrauterine insemination for the treatment of unexplained and mild male factor infertility
More informationPrognostic value of day 3 estradiol on in vitro fertilization outcome*
FERTILITY AND STERILITY Vol. 64, No.6, December 1995 Copyright 1995 American Society for Reproductive Medicine Printed on acid-free paper in U. S. A. Prognostic value of day 3 estradiol on in vitro fertilization
More informationA Tale of Three Hormones: hcg, Progesterone and AMH
A Tale of Three Hormones: hcg, Progesterone and AMH Download the Ferring AR ipad/iphone app from the Apple Store: http://bit.ly/1okk74m Interpreting Follicular Phase Progesterone Ernesto Bosch IVI Valencia,
More informationImpact of Varying Stages of Endometriosis on the Outcome of In Vitro Fertilization-Embryo Transfer
CLINICAL ASSISTED REPRODUCTION Impact of Varying Stages of Endometriosis on the Outcome of In Vitro Fertilization-Embryo Transfer LUBNA PAL,1,3 JAN L. SHIFREN,2 KEITH B. ISAACSON,1 YuCHIAO CHANG,2 LUCY
More informationMinimal stimulation protocol for use with intrauterine insemination in the treatment of infertility Dhaliwal L K, Sialy R K, Gopalan S, Majumdar S
Minimal stimulation protocol for use with intrauterine insemination in the treatment of infertility Dhaliwal L K, Sialy R K, Gopalan S, Majumdar S Record Status This is a critical abstract of an economic
More informationPrognosticating ovarian reserve by the new ovarian response prediction index
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Tak A et al. Int J Reprod Contracept Obstet Gynecol. 2018 Mar;7(3):1196-1200 www.ijrcog.org DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20180917
More informationCOMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL
COMPARING AMH, AFC AND FSH FOR PREDICTING HIGH OVARIAN RESPONSE IN WOMEN UNDERGOING ANTAGONIST PROTOCOL Nguyen Xuan Hoi1, Nguyen Manh Ha2 1 National Obstetrics and Gynecology Hospital, 2Hanoi Medical Unviversity
More informationK.W.Fuh, X.Wang, A.Tai, I.Wong and R.J.Norman 1
Human Reproduction vol.12 no.10 pp.2162 2166, 1997 Intrauterine insemination: effect of the temporal relationship between the luteinizing hormone surge, human chorionic gonadotrophin administration and
More informationBiology of fertility control. Higher Human Biology
Biology of fertility control Higher Human Biology Learning Intention Compare fertile periods in females and males What is infertility? Infertility is the inability of a sexually active, non-contracepting
More information' ' ' ' ' ' ' ' COMPARISON BETWEEN HIGHLY PURIFIED--FSH AND HMG FOR SUPEROVULATION IN WOMEN UNDERGOING IN VITRO FERTILIZATION ORIGINAL RESEARCH
' ' ' ' ORIGINAL RESEARCH ' ' ' ' COMPARISON BETWEEN HIGHLY PURIFIED--FSH AND HMG FOR SUPEROVULATION IN WOMEN UNDERGOING IN VITRO FERTILIZATION Pierre Miron, MD, FRCSC, 1 Robert Casper, MD, FRCSC,2 Louise
More informationEHY Ng, WSB Yeung, PC Ho. Introduction
Comparison of two dosages of recombinant human follicle-stimulating hormone in Chinese women undergoing controlled ovarian stimulation: prospective randomised double-blind study EHY Ng, WSB Yeung, PC Ho
More informationEmbryo Selection after IVF
Embryo Selection after IVF Embryo Selection after IVF Many of human embryos produced after in vitro fertilization carry abnormal chromosomes. Placing a chromosomally normal embryo (s) into a normal uterus
More informationInfluence ovarian stimulation on oocyte and embryo quality. Prof.Dr. Bart CJM Fauser
Influence ovarian stimulation on oocyte and embryo quality Prof.Dr. Bart CJM Fauser How to balance too much vs too little? Lecture Outline Context ovarian stimulation Impact ovarian stimulation on oocyte
More informationIs it the seed or the soil? Arthur Leader, MD, FRCSC
The Physiological Limits of Ovarian Stimulation Is it the seed or the soil? Arthur Leader, MD, FRCSC Objectives 1. To consider how ovarian stimulation protocols work in IVF 2. To review the key events
More informationThe influence of body mass index, basal FSH and age on the response to gonadotrophin stimulation in non-polycystic ovarian syndrome patients
Human Reproduction Vol.17, No.5 pp. 1207 1211, 2002 The influence of body mass index, basal FSH and age on the response to gonadotrophin stimulation in non-polycystic ovarian syndrome patients Sheila Loh
More informationThe facts about egg freezing
The facts about egg freezing 1800 111 483 qfg.com.au Who might benefit from egg freezing? Age-related infertility in women is one of the most common issues presented to fertility specialists each day when
More informationLink between effectiveness and cost data The costing was undertaken prospectively on the same patient sample that provided the effectiveness data.
Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-fsh vs. HPuFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis Revelli A, Poso F, Gennarelli
More informationIvf day 6 estradiol level
Ivf day 6 estradiol level Search It is also important to measure the estradiol on day 3. Day 2 is fine. The reason its day 3 is 15-20 years ago, the IVF medications were always started on day 3. Day 3
More informationAbstract. Introduction. RBMOnline - Vol 19. No Reproductive BioMedicine Online; on web 24 August 2009
RBMOnline - Vol 19. No 4. 2009 599 603 Reproductive BioMedicine Online; www.rbmonline.com/article/3872 on web 24 August 2009 Article Assisted reproduction in women over 40 years of age: how old is too
More informationRafael A. Cabrera, M.D., Laurel Stadtmauer, M.D., Ph.D., Jacob F. Mayer, Ph.D., William E. Gibbons, M.D., and Sergio Oehninger, M.D., Ph.D.
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant
More informationInfertility Clinical Guideline
Infertility Clinical Guideline Ovarian Stimulation Guideline Purpose: To provide sufficient background regarding various ovarian stimulation protocols for In Vitro Fertilization cycles. Goal: To assist
More informationPatient Overview: Invitro Fertilisation
Patient Overview: Overview IVF stands for in-vitro fertilisation i.e. literally fertilisation in a glass dish. You may also hear the term ART used which stands for Assisted Reproductive Technologies. IVF
More informationAssisted reproductive technology
Assisted reproductive technology FERTILITY AND STERILITY Vol. 60, No.2, August 1993 Copyright 'c; 199:~ The American Fertility Society Printed on acid-free paper in U. S. A. Natural cycle in vitro fertilization-embryo
More informationT39: Fertility Policy Checklist
Patient Name: Address: Date of Birth: NHS Number: Consultant/Service to whom referral will be made: Institution Lifestyle Information Latest BMI: Latest BP: Smoking Status: Has the patient been referred
More informationLOW COST PROTOCOL VERSUS SHORT PROTOCOL FOR CONTROLLED OVARIAN STIMULATION IN ICSI TRIALS
LOW COST PROTOCOL VERSUS SHORT PROTOCOL FOR CONTROLLED OVARIAN STIMULATION IN ICSI TRIALS Salem H. H. '; Nassar A. M.,&l ; Askalany N. A. ', Kassem K. 1&4 Department of Obstetrics and Gynecology Al Azhar
More informationAntral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
BJOG: an International Journal of Obstetrics and Gynaecology October 2005, Vol. 112, pp. 1384 1390 DOI: 10.1111/j.1471-0528.2005.00670.x Antral follicle count, anti-mullerian hormone and inhibin B: predictors
More informationArticle Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles
RBMOnline - Vol 6. No 4. 439 443 Reproductive BioMedicine Online; www.rbmonline.com/article/872 on web 7 April 2003 Article Conception rates following assisted reproduction in poor responder patients:
More informationFollicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation
Follicle-stimulating hormone/luteinizing hormone ratio as an independent predictor of response to controlled ovarian stimulation Aim: To determine whether a follicle-stimulating hormone (FSH)/luteinizing
More informationInfertility. Thomas Lloyd and Samera Dean
Infertility Thomas Lloyd and Samera Dean Infertility Definition Causes Referral criteria Assisted reproductive techniques Complications Ethics What is infertility? Woman Reproductive age Has not conceived
More informationSetting The setting was secondary care. The economic study was carried out in Turkey.
Letrozole versus human menopausal gonadotrophin in women undergoing intrauterine insemination Baysoy A, Serdaroglu H, Jamal H, Karatekeli E, Ozornek H, Attar E Record Status This is a critical abstract
More informationFertility Assessment and Treatment Pathway
Rejected referrals sent back to GP Fertility Assessment and Treatment Pathway Patients with fertility problems go to the GP GP Advice and Assessment GP to inform patient of access criteria for NHS-funded
More informationThe effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study
Clinical research The effect of adding oral oestradiol to progesterone as luteal phase support in ART cycles a randomized controlled study Ashraf Moini 1,2, Shahrzad Zadeh Modarress 3, Elham Amirchaghmaghi
More informationStudy on Several Factors Involved in IVF-ET of Human Beings
Study on Several Factors Involved in IVF-ET of Human Beings Lei X 1, Zhuoran W 1, Bin L 1, Huiming L 1, Hongxiu Z 1, Yajuan Z 1, Yingbo Q 1, Guixue Z 2 1 The First Clinical College of Harbin Medical University,
More informationPrognostic factors of ovarian response and IVF outcome in patients with deep infiltrating endometriosis Claire GAUCHE-CAZALIS, Chadi YAZBECK
Prognostic factors of ovarian response and IVF outcome in patients with deep infiltrating endometriosis Claire GAUCHE-CAZALIS, Chadi YAZBECK Obstetrics Gynecology and Reproductive Medicine Department Bichat
More informationA prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF
FVV IN OBGYN, 2012, 4 (2): 82-87 Original paper A prospective randomised study comparing a GnRH-antagonist versus a GnRH-agonist short protocol for ovarian stimulation in patients referred for IVF S. GORDTS,
More informationGoverning Body Meeting
Agenda Item No: 13 Date of Meeting: 26 th November 2015 Governing Body Meeting Paper Title: East and North Hertfordshire CCG (ENHCCG) Policy on Fertility treatment and referral criteria for specialist
More informationI. ART PROCEDURES. A. In Vitro Fertilization (IVF)
DFW Fertility Associates ASSISTED REPRODUCTIVE TECHNOLOGY (ART) Welcome to DFW Fertility Associates/ Presbyterian-Harris Methodist Hospital ARTS program. This document provides an overview of treatment
More informationInfertility treatment
In the name of God Infertility treatment Treatment options The optimal treatment is one that provide an acceptable success rate, has minimal risk and is costeffective. The treatment options are: 1- Ovulation
More informationIVF Patient Information
What is IVF? IVF (In Vitro Fertilisation) is a treatment by which fertilisation of eggs by sperm takes place outside the body in a dish in an IVF laboratory. An ovary has a pool of immature eggs. In a
More informationN.A.Bersinger 1, A.Brandenberger, E.Berger, C.K.Baumann and M.H.Birkhäuser
Human Reproduction vol.13 no.7 pp.1962 1967, 1998 Serum pregnancy-specific β 1 -glycoprotein before embryo transfer is related to endometrial thickness and to outcome prognosis in women undergoing in-vitro
More informationThe cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments Sykes D, Out H J, Palmer S J, van Loon J
The cost-effectiveness of IVF in the UK: a comparison of three gonadotrophin treatments Sykes D, Out H J, Palmer S J, van Loon J Record Status This is a critical abstract of an economic evaluation that
More informationIVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW
IVF AND PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) WHAT THE COMMUNITY PHYSICIAN NEEDS TO KNOW Jon Havelock, MD, FRCSC, FACOG Co-Director - PCRM Disclosure No conflict of interest in relation
More informationComparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization
Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization Peter Kovacs, M.D., a Timea Kovats, M.D., a Artur Bernard,
More informationLars G.Westergaard 1, Karin Erb, Steen Laursen, Per E.Rasmussen and Sven Rex
Human Reproduction vol.11 no.6 pp. 1209-1213, 19% The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertuization in
More informationIVF (,, ) : (HP-hMG) - (IVF- ET) : GnRH, HP-hMG (HP-hMG )57, (rfsh )140, (Gn)
34 11 Vol.34 No.11 2014 11 Nov. 2014 Reproduction & Contraception doi: 10.7669/j.issn.0253-3X.2014.11.0892 E-mail: randc_journal@163.com IVF ( 710003) : (H-hMG) - (IVF- ET) : GnRH H-hMG (H-hMG ) (rfsh
More informationThe Human Menstrual Cycle
The Human Menstrual Cycle Name: The female human s menstrual cycle is broken into two phases: the Follicular Phase and the Luteal Phase. These two phases are separated by an event called ovulation. (1)
More informationThe serum estradiol/oocyte ratio in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins
Original Article Obstet Gynecol Sci 2018;61(2):242-246 https://doi.org/10.5468/ogs.2018.61.2.242 pissn 2287-8572 eissn 2287-8580 The serum estradiol/oocyte ratio in patients with breast cancer undergoing
More informationSample size a Main finding b Main limitations
1 Table 1. Available studies on the relation between endometriosis and miscarriage (1995-2015). Study (citation) Country Study period Study design Sample size a Main finding b Main limitations Matoras
More informationORIGINAL ARTICLE ENDOMETRIAL THICKNESS AND PREGNANCY OUTCOME IN IUI CYCLES
ENDOMETRIAL THICKNESS AND PREGNANCY OUTCOME IN IUI CYCLES Asha Verma 1, Rekha Mulchandani 2, Nupur Lauria 3, Kusum Verma 4, Sunita Himani 5 HOW TO CITE THIS ARTICLE: Asha Verma, Rekha Mulchandani, Nupur
More informationMilder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization
Milder is better? Advantages and disadvantages of "mild" ovarian stimulation for human in vitro fertilization Revelli et al. Reproductive Biology and Endocrinology 2011, 9:25 Presenter: R2 孫怡虹 Background
More informationMinimal stimulation using recombinant follicle-stimulating hormone and a gonadotropin-releasing hormone antagonist in women of advanced age
FERTILITY AND STERILITY VOL. 81, NO. 4, APRIL 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Minimal stimulation using recombinant
More informationCOMMISSIONING POLICY. Tertiary treatment for assisted conception services
Final Version COMMISSIONING POLICY Tertiary treatment for assisted conception services Designated providers for patients registered with a Worcestershire GP BMI The Priory Hospital, Birmingham - 1 - Commissioning
More informationIntroduction to Intrauterine Insemination (IUI) Service
Introduction to Intrauterine Insemination (IUI) Service Assisted Reproductive Technology Unit The Chinese University of Hong Kong Prince of Wales Hospital 2017 Treatment Procedures IUI involves six main
More informationComplete failure of fertilization in couples with unexplained infertility: implications for subsequent in vitro fertilization cycles
r FERTILITY AND STERILITY Copyright ~ 1993 The American Fertility Society Printed on acid-free paper in U.S.A. Complete failure of fertilization in couples with unexplained infertility: implications for
More informationPhases of the Ovarian Cycle
OVARIAN CYCLE An ovary contains many follicles, and each one contains an immature egg called an oocyte. A female is born with as many as 2 million follicles, but the number is reduced to 300,000 to 400,000
More informationThe Presence of Hydrosalpinx May Not Adversely Affect the Implantation and Pregnancy Rates in In Vitro Fertilization Treatment1
CLINICAL ASSISTED REPRODUCTION The Presence of Hydrosalpinx May Not Adversely Affect the Implantation and Pregnancy Rates in In Vitro Fertilization Treatment1 ERNEST HUNG-YU NG,2,3 WILLIAM SHU-BIU YEUNG,2
More informationLUTEAL PHASE SUPPORT. Doç. Dr. Nafiye Yılmaz. Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi
LUTEAL PHASE SUPPORT Doç. Dr. Nafiye Yılmaz Zekai Tahir Burak Kadın Sağlığı Eğitim Araştırma Hastanesi TAJEV, 2014 1 ART & success *Live birth rate 2 Optimal luteal phase Etiology of luteal phase deficiency
More informationGn-RH Agonist Challenge Test for Predicting Ovarian Reserve in Short Protocol Cycles
J Obstet Gynecol lnd Vol. 54, No.1: January/February 2004 Pg 51-55 Gn-RH Agonist Challenge Test for Predicting Ovarian Reserve in Short Protocol Cycles Ocal Pelin, Cepni Ismail, Akbas Hande, Idil Mehmet,
More informationFertility care for women diagnosed with cancer
Saint Mary s Hospital Department of Reproductive Medicine Information for Patients Fertility care for women diagnosed with cancer Contents Page Overview... 2 Our service... 2 Effects of cancer treatment
More informationBumiputera Sarawak Bumiputera Sabah. Others Foreigner. Had previous natural pregnancy Previous IVF pregnancies. IVF live births.
a. Date of notification: b. Name of reporting site: c.name of doctor in charge: AI : FEMALE PATIENT DETAILS & DEMOGRAPHICS (Instruction: if Mykad is not available, please complete Old IC or other ID document
More information